lung cancer

2016 ASCO Annual Meeting: Collective Wisdom #ASCO16
June 5, 2016 · Greg Guthrie, ASCO staff
These studies from the ASCO Annual Meeting show some of the newest thoughts and latest advances in using immunotherapy and targeted therapy to treat bladder, stomach, and lung cancers. Read More >>
January 28, 2016
Patient advocate Dusty Donaldson reports from the 2016 Cancer Survivorship Symposium and discusses the growing support for survivorship care plans for all people with cancer. Read More >>
October 13, 2015 · Cat Snyder, ASCO staff
What is low dose CT screening for lung cancer? What are the benefits and risks? Should I ask my doctor about it? In this podcast, Dr. Bernardo Goulart answers these questions and more. Read More >>
May 29, 2015 · Amber Bauer, ASCO staff
Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers. Read More >>
May 5, 2015 · Cat Snyder, ASCO staff
In this podcast, experts discuss ASCO’s recent endorsement of ASTRO’s guideline for radiation therapy for non-small cell lung cancer. Read More >>

Pages